Disrupting NEDD8-Mediated Protein Turnover with MLN4924 Significantly Augments the Efficacy of Cytarabine
Steffan T. Nawrocki(University of Arizona), Jennifer S. Carew(University of Arizona), Devalingam Mahalingam(The University of Texas at San Antonio Health Science Center), Kevin R. Kelly(Keck Hospital of USC), Kelli Oberheu(The University of Texas at San Antonio Health Science Center), Peter G. Smith(Ollscoil na Gaillimhe – University of Galway)
Cited by 2
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505